N/A N=211 Randomized Treatment

Improving Chronic Illness Management With the Apsaalooke Nation: The Baa Nnilah Project

Chronic Disease

Bottom Line

View on ClinicalTrials.gov: NCT03036189 ↗

Enrolled (actual)

211

Serious AEs

0.0%

Results posted

Jun 2023

Primary outcome: Primary: SF-12 - Physical Health — 43.85; 43.64; 45.65; 45.18 score on a scale — p=0.50

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: baa nnilah (Behavioral)
Age: Adult, Older Adult · 25+ yrs
Sex: All
Sponsor: Montana State University
Primary completion: Jan 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY SF-12 - Physical Health	43.85; 43.64; 45.65; 45.18; 45.56; 44.50	0.50
PRIMARY SF-12 - Mental Health	43.85; 43.64; 45.65; 45.18; 45.56; 44.50	0.71
SECONDARY Patient Health Questionnaire-9	5.29; 7.22; 5.43; 6.24; 4.30; 5.50	0.83
SECONDARY PROMIS Satisfaction With Social Roles and Activities	53.62; 54.03; 53.26; 53.65; 53.61; 54.05	0.58
SECONDARY PROMIS Self-Efficacy for Managing Symptoms	49.33; 48.15; 48.48; 47.12; 50.45; 48.93	0.69
SECONDARY PROMIS Emotional Support	52.71; 51.65; 53.31; 53.36; 53.29; 52.32	0.60
SECONDARY PROMIS Positive Affect and Well-being	56.32; 56.37; 57.84; 57.37; 57.64; 57.15	0.97
SECONDARY PROMIS Physical Function	44.94; 45.49; 45.83; 45.55; 45.00; 45.23	0.49
SECONDARY PROMIS Self-efficacy for Managing Emotions	48.18; 48.28; 50.00; 49.18; 50.15; 49.90	0.77
SECONDARY PROMIS Self-efficacy for Managing Social Interactions	46.57; 47.44; 47.13; 47.86; 48.57; 47.18	<.05 sig
SECONDARY Patient Activation Measure	69.31; 65.50; 67.53; 70.61; 68.47; 71.67	0.40
SECONDARY Modified Timed Up and Go	20.83; 20.39; 19.26; 19.34; 17.18; 18.70	0.07
SECONDARY Modified Balance Error Scoring System	13.41; 13.81; 14.17; 12.68; 15.30; 11.91	0.84
SECONDARY 6-minute Walk	1260.23; 1298.85; 1336.75; 1358.96; 1060.11; 1283.54	0.64

Summary

This is a group randomized trial of an intervention to improve chronic illness self-management.

Eligibility Criteria

Inclusion Criteria

≥ 25 years
AI
diagnosed with diabetes
hypertension
osteoporosis
liver disease
chronic lung disease (asthma, chronic bronchitis or emphysema)
heart disease (coronary artery disease or congestive heart failure)
stroke (completed cerebrovascular accident with neurologic handicap and normal mentation)
chronic arthritis

Exclusion Criteria

major medical illness that precludes their attendance at 7 meetings
<25 years of age

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03036189). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.